Daily Brief Australia: Carnaby Resources, Mayne Pharma, Skycity Entertainment, Suncorp, Dalrymple Bay Infrastructure L, Maritana Minerals, Charter Hall, MSL Solutions Ltd. and more

• Back on the 27th July, gold/copper exploration play Carnaby Resources (CNB AU) entered into a Scheme with Evolution Mining (EVN AU).
• Evolution offered  0.0682 new shares for each Carnaby share, or an indicative Offer price of A$0.77/share, a 60.4% premium. Post merger, Carnaby shareholders would hold ~0.9% in the enlarged entity.
• Carnaby’s board unanimously support terms. Directors hold 7.3%. Retail pushback should be limited: scrip terms are now up ~41% since the Offer was announced.

• Financial Architecture Inflation: Mayne Pharma’s reported gross margins and EBITDA are structurally inflated by its balance sheet treatment of the TherapeuticsMD (TXMD) royalties. Instead of flowing through the P&L as Cost of Goods Sold (COGS) or operating expenses, the 8% royalty payments to TXMD are treated as a reduction of the balance sheet’s AUD 336.0 million deferred consideration liability, shielding operating profits from true commercial costs.
• The Cosette Transaction Double-Bind: While the NSW Supreme Court ruled in Mayne’s favor in October 2025, declaring that Cosette did not validly terminate its AUD 672.0 million takeover bid on MAC grounds, the deal was ultimately killed by the Australian Treasurer (FIRB) on national-interest grounds in November 2025. Current litigation is now a damages battle, with Mayne accusing Cosette of intentionally sandbagging the FIRB process to walk away from a deteriorating asset base.
• DistributeRx Execution Risk: Launched in March 2026, the DistributeRx direct-to-patient model is an aggressive attempt to disintermediate the traditional U.S. payer-wholesaler value chain. While prescription volumes rose to 62,000 in its first full quarter, the strategy shifts commercial risk entirely onto Mayne’s balance sheet, requiring a major capital outlay for Adelaide Apothecary’s new Lexington facility to support a target capacity of 2.5 million annual prescriptions.

• Valuation Disconnect and SOTP Opportunity: The Board’s rejection of Oaktree’s NZ$0.70 and Iris Capital’s NZ$0.75 unsolicited bids in May 2026 highlights a massive SOTP gap. Auckland is priced as a distressed asset despite its flagship status and NZ$179.8 million in FY26 underlying EBITDA. Applying a standard 9.0x to 10.0x EV/EBITDA multiple to Auckland alone yields an implied asset value of NZ$1.62 billion to NZ$1.80 billion, significantly exceeding the entire group’s current enterprise value of roughly NZ$1.15 billion.
• Regulatory Drag and Margin Compression: Ongoing structural compliance opex remains sticky, driven by Adelaide’s Building a Better Business (B3) remediation program being delayed to early FY28. This, combined with the NZ$20 million to NZ$30 million EBITDA hit from the mandatory carded-play rollout in New Zealand and a NZ$32.0 million increase in labor costs to NZ$373.7 million, has compressed reported EBITDA margins to 13.7% and underlying EBITDA margins to 22.1%.
• Management Execution and Back-Office Cost-Outs: Newly appointed CEO Jason Walbridge’s execution under his NZ$2.72 million compensation package faces deep skepticism. While the legacy Performance Incentive Plan (PIP) has been phased out, the board’s alignment with minority shareholders is under pressure. The market is highly critical of the board’s preference for a standalone turnaround over a clean buyout, especially as the group pushes a painful restructuring targeting NZ$30 million in FY27 savings (potentially impacting 200 to 250 roles) and NZ$70 million by FY28.

• Pure-Play Simplification Triggers Takeover Interest: Following the completion of the Suncorp Bank sale to ANZ in July 2024 and the Asteron Life NZ divestment in January 2025, Suncorp is now a highly attractive, clean general insurance target. Tokio Marine’s rumored interest is a direct consequence of this “pure-play” corporate simplification, which removes conglomerate complexity and lowers absolute acquisition hurdles.
• Favorable Regulatory Path for Foreign Entrants: Unlike a domestic merger (e.g., Suncorp-IAG) which would face an insurmountable veto from the Australian Competition and Consumer Commission (ACCC), a foreign-led buyout by Tokio Marine is highly likely to clear regulatory hurdles. APRA and FIRB will focus extensively on data sovereignty, capital adequacy, and keeping operational functions local, but historic precedents like Dai-ichi’s acquisition of TAL suggest these are administrative hurdles rather than deal-killers.
• Reinsurance and Weather Resilience Redefine Valuation: Suncorp’s newly established five-year aggregate reinsurance arrangement (effective July 1, 2026) and its newly structured FY27 catastrophe reinsurance tower (covering $500 million to $6.4 billion) successfully cap earnings volatility. By transferring natural hazard risk off the balance sheet, Suncorp becomes a far more predictable utility-like cash generator, justifying the rumored A$20.00 to A$21.50 per share takeover valuation range.

• Dalrymple Bay Infrastructure has appeal to investors seeking dependable and growing yield and defensive elements for their portfolio.
• Dalrymple Bay Infrastructure’s first half result in line with consensus Full year dividend guidance suggests 8% growth Approximately $371m of NECAP projects underway The company benefits from attractive risk mitigants

• Maritana Minerals Limited (ASX:MRT) is an emerging junior gold producer with 1.9moz of gold resources located around the Kalgoorlie and Coolgardie regions of Western Australia.
• MRT is underway on the Black Swan Processing Hub (BSPH) development, which transforms the company into a standalone gold producer.
• The study detailed production of 102kozpa, which at the current gold price would result in significant cash flows.

• Charter Hall Group posted an FY26 result in line with consensus but FY27 guidance slightly missed consensus.
• Analysts point to a track record of upgrading guidance through the year.
• Charter Hall’s FY26 result in line with guidance and consensus FY27 guidance a small miss to consensus Analysts are unperturbed, noting a history of guidance upgrades Positive views all round

• Turnaround and Enterprise Expansion: MSL Solutions Limited has engineered an operational and financial turnaround, transitioning from legacy platforms and pandemic-related headwinds to an enterprise-grade sports and hospitality SaaS business, delivering FY22 revenue of A$33.93 million (up 37.6% YoY) and a 3-year revenue CAGR of 7.20%.
• Dominant Footprint in High-Concurrency Venues: The company has established a market-leading position across Australia, New Zealand, and the UK, powering major sporting arenas, convention centers, and golf federations (over 8,000 venues globally) through core proprietary platforms including SwiftPOS, OrderMate, and GolfBox.
• Strong Cash Flow Conversion and Balance Sheet Health: Operating cash flow increased to A$4.09 million in FY22 (reflecting a 3-year CAGR of 39.13% and 3-year Free Cash Flow CAGR of 38.61%), supported by gross margin expansion to 45.93%, positive EBITDA margins of 14.06%, and zero interest-bearing debt.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.